Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma https://t.co/zHC3ByAcW6
Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma https://t.co/aCsfrRa3IY
New article: Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma https://t.co/6LSDTWVGWZ #melanoma #oncology https://t.co/BOxEVXCAdr
RT @sarah_sasson: Just published! "Identification of neutralising pembrolizumab anti-drug antibodies (ADAs) in patients with melanoma" @Sci…
RT @Dr_LauraW: So immensely proud to have our work published in @SciReports. Thank you so much @sarah_sasson for letting me work with you o…
So immensely proud to have our work published in @SciReports. Thank you so much @sarah_sasson for letting me work with you on this project! -> Neutralising anti-drug antibody levels measured in a real world cohort of patients receiving Pembrolizumab fo
Just published! "Identification of neutralising pembrolizumab anti-drug antibodies (ADAs) in patients with melanoma" @SciReports . We found the rate of neutralising ADAs (7%) was higher in our real world cohort than has been previously reported. 1/2 https